Key result
In nondiabetic individuals, higher HbA1c was associated with worse endothelial function (r = -0.162, P = 0.004), but this association was only present in lean individuals (r = -0.215, P = 0.009).
Why the study?
Is long-term glycemia associated with endothelial dysfunction in healthy nondiabetic individuals, and does body weight modify this association?
Cross-Sectional (n=309)
Is long-term glycemia associated with endothelial dysfunction in healthy nondiabetic individuals, and does body weight modify this association?
In nondiabetic individuals, long-term glycemia is associated with endothelial dysfunction only in lean individuals, suggesting obesity may share mechanisms that mask this effect.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for glycemia's endothelial effects in lean nondiabetics; leaves open obesity modification and requires longitudinal confirmation.
The aim of this study was to examine the association between glycemia and markers of early atherosclerosis in healthy nondiabetic individuals. In 309 individuals without diabetes or symptomatic cardiovascular disease, we assessed long-term glycemia by glycosylated hemoglobin (HbA1c) and endothelial function by flow-mediated dilatation (FMD) in the brachial artery. HbA1c was negatively associated with FMD (r = -0.162, P = 0.004). Multivariate linear regression analysis after adjusting for common risk factors of cardiovascular disease showed that BMI was an effect modifier of the association between HbA1c and FMD (P = 0.034 for the HbA1c x BMI interaction). We stratified the FMD outcome data into two groups separated by the median BMI (group 1: BMI < or = 26.1 kg/m(2) and group 2: BMI > 26.1 kg/m(2)). In the lower BMI group, HbA1c was an independent predictor of FMD even when adjusted for confounding factors associated with impaired glucose metabolism (r = -0.215, P = 0.009), but in the higher BMI group HbA1c was not associated with FMD (r = -0.051, P = 0.5). In a nondiabetic population, long-term glycemia was associated with endothelial dysfunction only in lean individuals. In the overweight individuals, this association was not apparent, possibly because some of the mechanisms that mediate the effect of glycemia on vascular function are shared by obesity.
No takes yet. Share an insight, caveat, or question.
Voidonikola et al. (2008) conducted a cross-sectional in Healthy nondiabetic individuals (n=309). Glycosylated hemoglobin (HbA1c) was evaluated on Endothelial function by flow-mediated dilatation (FMD) in the brachial artery (r = -0.162, p=0.004). In nondiabetic individuals, higher HbA1c was associated with worse endothelial function (r = -0.162, P = 0.004), but this association was only present in lean individuals (r = -0.215, P = 0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: